MYKROX Drug Patent Profile
✉ Email this page to a colleague
When do Mykrox patents expire, and when can generic versions of Mykrox launch?
Mykrox is a drug marketed by Chartwell Molecular and is included in one NDA.
The generic ingredient in MYKROX is metolazone. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mykrox
A generic version of MYKROX was approved as metolazone by SANDOZ on December 19th, 2003.
Summary for MYKROX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Patent Applications: | 4,839 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MYKROX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MYKROX
US Patents and Regulatory Information for MYKROX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Molecular | MYKROX | metolazone | TABLET;ORAL | 019532-001 | Oct 30, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MYKROX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chartwell Molecular | MYKROX | metolazone | TABLET;ORAL | 019532-001 | Oct 30, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MYKROX
See the table below for patents covering MYKROX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Israel | 71506 | ⤷ Try a Trial | |
New Zealand | 207678 | RAPID DISSOLVING DRUG COMPOSITIONS CONTAINING MICROCRYSTALLINE CELLULOSE AND STARCH | ⤷ Try a Trial |
Germany | 3482402 | ⤷ Try a Trial | |
Australia | 565640 | ⤷ Try a Trial | |
Australia | 2643484 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |